Related references
Note: Only part of the references are listed.What We Talk About When We Talk About Fat
Evan D. Rosen et al.
CELL (2014)
Mitochondrial alteration in type 2 diabetes and obesity An epigenetic link
Zhiyong Cheng et al.
CELL CYCLE (2014)
Targeting mitochondrial alterations to prevent type 2 diabetes-Evidence from studies of dietary redox-active compounds
Zhiyong Cheng et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2014)
Progesterone receptors induce FOXO1-dependent senescence in ovarian cancer cells
Caroline H. Diep et al.
CELL CYCLE (2013)
Tracking adipogenesis during white adipose tissue development, expansion and regeneration
Qiong A. Wang et al.
NATURE MEDICINE (2013)
High Glucose Induced Alteration of SIRTs in Endothelial Cells Causes Rapid Aging in a p300 and FOXO Regulated Pathway
Rokhsana Mortuza et al.
PLOS ONE (2013)
Protocol for effective differentiation of 3T3-L1 cells to adipocytes
Katja Zebisch et al.
ANALYTICAL BIOCHEMISTRY (2012)
The AKTion in non-canonical insulin signaling
Zhiyong Cheng et al.
NATURE MEDICINE (2012)
Mitochondrial dysfunction in white adipose tissue
Christine M. Kusminski et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2012)
Targeting Forkhead Box O1 from the Concept to Metabolic Diseases: Lessons from Mouse Models
Zhiyong Cheng et al.
ANTIOXIDANTS & REDOX SIGNALING (2011)
Foxo1 in hepatic lipid metabolism
Zhiyong Cheng et al.
CELL CYCLE (2010)
(-) Epigallocatechin gallate suppresses the differentiation of 3T3-L1 preadipocytes through transcription factors FoxO1 and SREBP1c
Hyojung Kim et al.
CYTOTECHNOLOGY (2010)
Diabetes and obesity: therapeutic targeting and risk reduction - a complex interplay
Kevin Niswender
DIABETES OBESITY & METABOLISM (2010)
Discovery of Novel Forkhead Box O1 Inhibitors for Treating Type 2 Diabetes: Improvement of Fasting Glycemia in Diabetic db/db Mice
Takeyuki Nagashima et al.
MOLECULAR PHARMACOLOGY (2010)
Insulin signaling meets mitochondria in metabolism
Zhiyong Cheng et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2010)
Mitochondrial (Dys)function in Adipocyte (De)differentiation and Systemic Metabolic Alterations
Aurelia De Pauw et al.
AMERICAN JOURNAL OF PATHOLOGY (2009)
FoxO1 Haploinsufficiency Protects Against High-Fat Diet-Induced Insulin Resistance With Enhanced Peroxisome Proliferator-Activated Receptor γ Activation in Adipose Tissue
Jane J. Kim et al.
DIABETES (2009)
Forkhead transcription factor Foxo1 is essential for adipocyte differentiation
Keisuke Munekata et al.
IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL (2009)
FOXO1 Transrepresses Peroxisome Proliferator-activated Receptor γ Transactivation, Coordinating an Insulin-induced Feed-forward Response in Adipocytes
WuQiang Fan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
The Irs1 Branch of the Insulin Signaling Cascade Plays a Dominant Role in Hepatic Nutrient Homeostasis
Shaodong Guo et al.
MOLECULAR AND CELLULAR BIOLOGY (2009)
Foxo1 integrates insulin signaling with mitochondrial function in the liver
Zhiyong Cheng et al.
NATURE MEDICINE (2009)
Inactivation of hepatic Foxo1 by insulin signaling is required for adaptive nutrient homeostasis and endocrine growth regulation
Xiaocheng C. Dong et al.
CELL METABOLISM (2008)
Developmental origin of fat: Tracking obesity to its source
Stephane Gesta et al.
CELL (2007)
Transcriptional control of adipocyte formation
Stephen R. Farmer
CELL METABOLISM (2006)
FOXO1 represses peroxisome proliferator-activated receptor-γ1 and -γ2 gene promoters in primary adipocytes -: A novel paradigm to increase insulin sensitivity
Michal Armoni et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Convergence of peroxisome proliferator-activated receptor γ and Foxo1 signaling pathways
P Dowell et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
The forkhead transcription factor Foxo1 regulates adipocyte differentiation
J Nakae et al.
DEVELOPMENTAL CELL (2003)
Share Paper
